Clinical Trial Update: Safety and Efficacy Study of Fipamezole in Treatment of Motor Dysfunctions in Parkinson's Disease [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating fipamezole for motor dysfunction in Parkinson's disease has completed, reporting on safety and efficacy.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Parkinson Disease

Drugs mentioned

• Fipamezole

Snippet

Sponsor: Juvantia Pharma Ltd | Conditions: Parkinson's Disease | Phase 2 | Status: COMPLETED